Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
  • Programs
    • Programs search
  • Data dashboards
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • Action plans
    • Hepatitis B Birth Dose Vaccine
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing
    • COVID-19
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
      • COVID-19 and Liver Disease Synthesis
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
  • Resources
    • Hepatitis Elimination Help Desk
    • Search resources
  • Webinars
    • Hep Test
    • Strategic Information Collaborative
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV testing
  • Hepatitis B
  • Hepatitis C
  • HBV testing and linkage to care
  • HCV testing and linkage to Care
  • Linkage to care
  • Screening and diagnosis
  • Testing
  • Adolescents (10 - 19 years of age)
  • Adults
  • Adults (> 19 years of age)
  • All ages
  • Birth cohorts of adults
  • General Population
  • Incarcerated populations (current and former)
  • Men who have sex with men
  • People experiencing homelessness
  • Persons who inject drugs
  • Persons with substance use disorder
  • Young Adults <21
  • Cross-sectional
  • Prospective cohort
  • Randomized control trial
  • Retrospective cohort
  • Australia
  • Brazil
  • Cambodia
  • Canada
  • Chad
  • Egypt
  • France
  • Georgia
  • Hong Kong
  • India
  • Iran (Islamic Republic of)
  • Ireland
  • Italy
  • Kenya
  • Pakistan
  • Poland
  • Spain
  • Switzerland
  • Ukraine
  • United Kingdom
  • United States of America
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • Laboratory-based antibody test, Point-of-care PCR/RNA test
  • Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based PCR/RNA (confirmatory) test
  • (-) Point-of-care antibody test (rapid test)
  • Point-of-care antibody test (rapid test), Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test), Point-of-care PCR/RNA test
  • Point-of-care antibody test (rapid test), Laboratory-based HCV core antigen (cAg) confirmatory test
  • Point-of-care PCR/RNA test
Displaying 1 - 12 of 49
  • Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs

    2014
    BMC Public Health

    14

    645
  • High hepatitis C infection rate among baby boomers in an urban primary care clinic: Results from the HepTLC initiative

    2016
    Public Health Reports

    131

    49-56
  • Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations

    Journal of public health management and practice : JPHMP

    24

    41-48
  • Public health clinic-based hepatitis C testing and linkage to care in Baltimore

    2016
    Journal of Viral Hepatitis

    23

    366-374
  • Senior Center-Based Hepatitis C Screening in Baltimore

    2016
    Open Forum Infectious Diseases

    3

    1-3
  • Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil

    2020
    BMC Infectious Diseases

    20

  • A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area

    2020
    PLoS ONE

    15

  • Use and acceptability of salivary hepatitis C virus testing in an English Young Offender Institution

    2017
    International Journal of STD & AIDS

    28

    1234-1238
  • Hepatitis C virus transmission in a skilled nursing facility, North Dakota, 2013

    2017
    American Journal of Infection Control

    45

    126-132
  • Usefulness of simultaneous screening for HIV and hepatitis C-specific antibodies and hepatitis B surface antigen by capillary-based multiplex immunochromatographic rapid test to strengthen prevention strategies and linkage to care in childbearing-aged wom

    2018
    Open Forum Infectious Diseases

    5

  • Simultaneous human immunodeficiency virus-hepatitis B-hepatitis C point-of-care tests improve outcomes in linkage-to-care: Results of a randomized control trial in persons without healthcare coverage

    2015
    Open Forum Infectious Diseases

    2

  • Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results: A Randomized Trial

    2020
    Medical care

    58

    445-452

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2021 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q